Search results
Found 7364 matches for
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
©
John Cairns
Biomedical Training Courses
Our courses are aimed at people who are applying to the Home Office for Personal or Project Licences.
Find Out More
Updates about the ESM pilot